HIGH

Westminster Pharmaceuticals Recalls Metoprolol Tartrate Tablets Due to Nitrosamine Hazard

Westminster Pharmaceuticals recalled 4,456 bottles of Metoprolol Tartrate Tablets on August 6, 2025. The recall follows the detection of a nitrosamine, N-nitroso-metoprolol, above acceptable daily intake levels. Consumers should immediately stop using this medication and consult healthcare providers.

Quick Facts at a Glance

Recall Date
August 6, 2025
Hazard Level
HIGH
Brands
Metoprolol Tartrate, Westminster Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Westminster Pharmaceuticals LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Product Details

The recall involves Metoprolol Tartrate Tablets, USP, 100 mg, distributed by Westminster Pharmaceuticals. The affected batches include R56240011, R56240021, R56240031, R56240041, R56240051, R56240061, and R56240071, with expiration dates ranging from February 28, 2026, to July 31, 2026.

The Hazard

The recalled tablets contain N-nitroso-metoprolol, a nitrosamine that exceeds the established Acceptable Daily Intake level. Nitrosamines are known to pose potential cancer risks.

Reported Incidents

There are no reported incidents or injuries associated with this recall at this time. The recall is classified as Class II due to the potential health risk.

What to Do

Consumers must stop using Metoprolol Tartrate Tablets immediately. Contact Westminster Pharmaceuticals or a healthcare provider for further guidance.

Contact Information

For more information, contact Westminster Pharmaceuticals at their customer service number or visit their website. Additional details can be found on the FDA recall page.

Key Facts

  • Recall date: August 6, 2025
  • Quantity recalled: 4,456 bottles
  • Affected product: Metoprolol Tartrate Tablets, USP, 100 mg
  • Hazard: N-nitroso-metoprolol detected above ADI level
  • Classification: Class II

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Batch # R56240011
Batch # R56240021
Batch # R56240031
Batch # R56240041
Batch # R56240051
+2 more
UPC Codes
69367-354
69367-355
69367-354-10
+3 more
Affected States
ALL
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more